- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04051723
Pre-emptive Scalp Infiltration With Dexamethasone Plus Ropivacaine for Post-Craniotomy Pain in Children
July 19, 2020 updated by: Fang Luo, Beijing Tiantan Hospital
At present, pediatric postoperative analgesia has not been fully understood and controlled, particularly craniotomy surgery.
On the one hand, professional evaluation of postoperative pain for young children is difficult; on the other hand, the particularity of craniotomy adds (such as consciousness obstacle, sleepiness, et al) disturbance to the pain assessment in children.
Although opioids administration is regarded as the first-line analgesic for post-craniotomy pain management, it may be associated with delayed awakening, respiratory depression, hypercarbia and it may interfere with the neurologic examination.
For the avoidance of side-effects of systemic opioids, local anesthetics administered around the incision have been performed clinically.
However, some studies revealed that the analgesic effect of local anesthetics was unsatisfactory due to its short pain relief duration, steroid as adjuvant can enhance postoperative analgesia and prolong postoperative analgesia time.
As is reported that postoperative pain of craniotomy is mainly caused by skin incision and reflection of muscles, preventing the liberation of inflammatory mediators around the incision seems to be more effective than simply blocking nerve conduction.
Researchers have clarified that the addition of dexamethasone to local infiltration of analgesia could provide significant analgesic effects and significantly prolong the duration of analgesic effects without obvious complications for various types of surgeries.
To date, no studies have evaluated the addition of dexamethasone to local infiltration for patients receiving craniotomy.
Thus, investigators suppose that pre-emptive scalp infiltration with steroid (Dexamethasone) plus local anesthetic (ropivacaine) could relieve postoperative pain after craniotomy in children.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100050
- Beijing TianTan Hospital
-
Beijing, Beijing, China
- Beijing Children's hospital affiliated to capital medical university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 12 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- An elective craniotomy under general anesthesia;
- American Society of Anesthesiologists (ASA) physical status of I or II;
- Participates with an anticipated fully recovery within 2 hours postoperatively;
- Informed consent by parent(s) and/or legal guardian.
Exclusion Criteria:
- History of allergies to any of the study drugs;
- Drugs with confirmed or suspected sedative or analgesic effects; receiving any painkiller within 24 h before surgery; children who received steroids;
- Psychiatric disorders;
- Uncontrolled epilepsy;
- Chronic headache;
- Peri-incisional infection;
- Body mass index exceeded the 99th percentile for age;
- Children who must use a patient-controlled analgesia (PCA) device;
- Children who cannot understand an instruction of pain scales before surgery.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: The dexamethasone plus ropivacaine group
Patients in the dexamethasone plus ropivacaine group will receive a peri-incisional scalp infiltration with 0.025% dexamethasone and 0.2% ropivacaine and normal saline miscible liquids.
|
The local infiltration solution containing 0.25mg Dexamethasone and 2mg ropivacaine per milliliter.
The total volume is 20 ml.
The assigned solution will be injected subcutaneously by surgeons along the incision and throughout the entire thickness of the scalp before skin incision.
The volume of local infiltration solution will be decided by surgeons according to the cut length, and the capacity of the solution will be recorded by investigators.
|
ACTIVE_COMPARATOR: The ropivacaine group
Patients in the ropivacaine group will receive a peri-incisional scalp infiltration with 0.2% ropivacaine and normal saline miscible liquids.
|
The local infiltration solution containing 2mg ropivacaine per milliliter.
The total volume is 20 ml.
The assigned solution will be injected subcutaneously by surgeons along the incision and throughout the entire thickness of the scalp before skin incision.
The volume of local infiltration solution will be decided by surgeons according to the cut length, and the capacity of the solution will be recorded by investigators.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
modified Children's Hospital of Eastern Ontario Pain Scale (mCHEOPS)
Time Frame: At 24 hours after the operation
|
Postoperative pain will be estimated by using the modified Children's Hospital of Eastern Ontario Pain Scale (mCHEOPS).
0 indicates no pain, 10 indicates the most severe pain imaginable.
|
At 24 hours after the operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wound Healing Score
Time Frame: At 1 month after surgery
|
Skin Healing 1: fully healed; 2: ≤3 cm in total not healed; 3: >3 cm not healed; 4: areas of necrosis ≤3 cm; 5: areas of necrosis >3 cm Infection 1: none; 2: ≤0.5-cm margin of redness; 3: more redness or superficial pus; 4: deep infection; not applicable Hair Regrowth 1: even regrowth along wound; 2: ≤3 cm not regrowing; 3: >3-6 cm not regrowing; 4: >6 cm not regrowing; not applicable
|
At 1 month after surgery
|
Heart rate
Time Frame: During the operation and at 2 hours, 4 hours, 8 hours, 24 hours after surgery
|
During the operation and at 2 hours, 4 hours, 8 hours, 24 hours after surgery
|
|
Mean arterial pressure
Time Frame: During the operation and at 2 hours, 4 hours, 8 hours, 24 hours after surgery
|
During the operation and at 2 hours, 4 hours, 8 hours, 24 hours after surgery
|
|
The total consumption of opioids during the operation
Time Frame: During procedure
|
During procedure
|
|
The total consumption of anaesthetic during the operation
Time Frame: During procedure
|
During procedure
|
|
modified Children's Hospital of Eastern Ontario Pain Scale (mCHEOPS)
Time Frame: At 2 hours, 4 hours, 8 hours, 48 hours, 72 hours, 1 week, 2 weeks after surgery
|
Postoperative pain will be estimated by using the modified Children's Hospital of Eastern Ontario Pain Scale (mCHEOPS).
0 indicates no pain, 10 indicates the most severe pain imaginable.
|
At 2 hours, 4 hours, 8 hours, 48 hours, 72 hours, 1 week, 2 weeks after surgery
|
The time to the first rescue analgesic
Time Frame: Within 48 hours after the operation
|
Rescue analgesics will be administered if the patient exhibits signs of sympathetic stimulation in the form of undue tachycardia, a rise in mean arterial pressure (rise of >20% from the baseline), and mCHEOPS score above 5 (range 1 to 10) or if the children are in obvious pain and distress at any time point during a subjective assessment by the intensivist or parents.
|
Within 48 hours after the operation
|
Patient satisfactory scale (PSS)
Time Frame: At 2 hours, 4 hours, 8 hours, 48 hours, 72 hours, 1 week, 2 weeks after surgery
|
0 for unsatisfactory, and 10 for very satisfied
|
At 2 hours, 4 hours, 8 hours, 48 hours, 72 hours, 1 week, 2 weeks after surgery
|
length of stay (LOS)
Time Frame: Approximately 2 weeks after the operation
|
LOS will be recorded as the number of nights spent in hospital after surgery.
|
Approximately 2 weeks after the operation
|
The occurrence of postoperative nausea and vomiting (PONV)
Time Frame: At 2 hours, 4 hours, 8 hours, 24 hours after surgery
|
PONV will be rated by participants as: 0, absent; 1, nausea not requiring treatment; 2, nausea requiring treatment; and 3, vomiting.
|
At 2 hours, 4 hours, 8 hours, 24 hours after surgery
|
Ramsay Sedation Scale (RSS)
Time Frame: At 2 hours, 4 hours, 8 hours, 24 hours after surgery
|
1: Anxious, agitated, restless; Ramsey 2: Cooperative, oriented, tranquil; Ramsey 3: Responsive to commands only If Asleep; Ramsey 4: Brisk response to light glabellar tap or loud auditory stimulus; Ramsey 5: Sluggish response to light glabellar tap or loud auditory stimulus; Ramsey 6: No response to light glabellar tap or loud auditory stimulus.
|
At 2 hours, 4 hours, 8 hours, 24 hours after surgery
|
The occurrence of respiratory depression
Time Frame: Within 48 hours after the operation
|
Respiratory depression is defined as persistent (more than 1 minutes) oxygen desaturation 90 percent or respiratory rate less than 8 breaths per minute, or oxygen desaturation less than 94 percent along with respiratory rate less than 10 breaths per minute requiring supplemental oxygen to maintain oxygen saturation more than 94 percent in the absence of clinically obvious upper airway obstruction.
|
Within 48 hours after the operation
|
Incisional related adverse events
Time Frame: Approximately 2 weeks after the operation
|
Incisional related adverse events Including delayed incisional healing, incisional infection, intracranial infection, scar healing.
|
Approximately 2 weeks after the operation
|
The occurrence of the Adverse events (AEs) and serious adverse events (SAEs)
Time Frame: Within 2 weeks after the operation
|
An AE was defined as any untoward medical occurrence.
An SAE included death, immediately life-threatening conditions, coma, in-patient hospitalisation or prolongation of existing hospitalisation.
|
Within 2 weeks after the operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ming Ge, M.D., Beijing Children' Hospital, Capital Medical University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Basali A, Mascha EJ, Kalfas I, Schubert A. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology. 2000 Jul;93(1):48-54. doi: 10.1097/00000542-200007000-00012.
- Bronco A, Pietrini D, Lamperti M, Somaini M, Tosi F, del Lungo LM, Zeimantz E, Tumolo M, Lampugnani E, Astuto M, Perna F, Zadra N, Meneghini L, Benucci V, Bussolin L, Scolari A, Savioli A, Locatelli BG, Prussiani V, Cazzaniga M, Mazzoleni F, Giussani C, Rota M, Ferland CE, Ingelmo PM. Incidence of pain after craniotomy in children. Paediatr Anaesth. 2014 Jul;24(7):781-7. doi: 10.1111/pan.12351. Epub 2014 Jan 28.
- Law-Koune JD, Szekely B, Fermanian C, Peuch C, Liu N, Fischler M. Scalp infiltration with bupivacaine plus epinephrine or plain ropivacaine reduces postoperative pain after supratentorial craniotomy. J Neurosurg Anesthesiol. 2005 Jul;17(3):139-43. doi: 10.1097/01.ana.0000171730.41008.da.
- Ikeuchi M, Kamimoto Y, Izumi M, Fukunaga K, Aso K, Sugimura N, Yokoyama M, Tani T. Effects of dexamethasone on local infiltration analgesia in total knee arthroplasty: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc. 2014 Jul;22(7):1638-43. doi: 10.1007/s00167-013-2367-5. Epub 2013 Jan 11.
- Ju NY, Cui GX, Gao W. Ropivacaine plus dexamethasone infiltration reduces postoperative pain after tonsillectomy and adenoidectomy. Int J Pediatr Otorhinolaryngol. 2013 Nov;77(11):1881-5. doi: 10.1016/j.ijporl.2013.08.037. Epub 2013 Sep 8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 2, 2019
Primary Completion (ACTUAL)
June 5, 2020
Study Completion (ACTUAL)
July 5, 2020
Study Registration Dates
First Submitted
August 8, 2019
First Submitted That Met QC Criteria
August 8, 2019
First Posted (ACTUAL)
August 9, 2019
Study Record Updates
Last Update Posted (ACTUAL)
July 21, 2020
Last Update Submitted That Met QC Criteria
July 19, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Pain, Postoperative
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Antiemetics
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Anesthetics, Local
- Dexamethasone
- Ropivacaine
Other Study ID Numbers
- KY 2018-066-02-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
Clinical Trials on The dexamethasone plus ropivacaine
-
The Cleveland ClinicTerminatedDuration of Interscalene BlockUnited States
-
Beijing Tiantan HospitalActive, not recruitingPain, PostoperativeChina
-
Beijing Tiantan HospitalCompleted
-
Kaohsiung Medical University Chung-Ho Memorial...UnknownAnalgesia | Motor Activity | Brachial Plexus BlockTaiwan
-
Seoul National University HospitalRecruitingDiabetic Foot | Diabetic NeuropathiesKorea, Republic of
-
Beijing Tiantan HospitalBeijing Children's HospitalRecruitingPain | Postoperative ChildrenChina
-
Baqiyatallah Medical Sciences UniversityShahid Beheshti University; Tehran University of Medical SciencesCompletedVentilator-associated Pneumonia
-
Landeskrankenhaus FeldbachMedical University of GrazUnknown
-
University of Maryland, BaltimoreNational Institute on Aging (NIA)Completed
-
Centre Hospitalier Universitaire, AmiensCompleted